Skip to content

For Research & Educational Discussion Only. Not Medical Advice

Baseline · Research Archive

The research archive, openly discussed.

A member-supported educational community. Every compound gets a plain-language guide of what the studies actually showed and where the evidence runs out, and every guide opens onto its own forum, so the reference material and the argument about it live in one place.

Research and educational discussion only — not medical advice

11Compounds
75Studies indexed
50Discussions
Featured
BPC-157
PreclinicalUnapproved

BPC-157

Synthetic pentadecapeptide (gastric peptide fragment)

A 15-amino-acid sequence with a large, remarkably consistent animal literature, almost all of it from a small affiliated research network, and no completed human trial reporting results.

2Studies indexed
MembersDiscussions
0Following
MT-2
Preclinical

Melanotan II (MT-2)

Non-selective melanocortin receptor agonist

A non-selective melanocortin agonist with a documented adverse event record including case reports of changing and new melanocytic lesions. Included as a catalogue entry precisely because of that record.

2studies1Available to members
GHK-Cu

GHK-Cu

Copper-binding tripeptide

A copper-binding tripeptide with extensive in vitro data and modest topical cosmetic evidence. The gap between the gene-expression literature and what topical application does is very wide.

Mechanistic2studies2Available to members
MOTS-c

MOTS-c

Mitochondrial-derived peptide

A mitochondrial-derived peptide with interesting metabolic biology in mice and essentially no human interventional data. Currently a research finding, not a therapy.

Mechanistic2studies1Available to members
Hexarelin

Hexarelin

Ghrelin receptor agonist / growth hormone secretagogue

A potent GH secretagogue with pronounced tachyphylaxis and a separate cardiac literature that is more interesting than its GH effects.

Preclinical1studies1Available to members
IGF-1 LR3

IGF-1 LR3

Modified insulin-like growth factor 1 analogue

A cell-culture reagent, engineered to evade the binding proteins that regulate IGF-1 in the body. That modification is exactly why it should not be administered to people.

Preclinical1studies1Available to members
FS-344
Mechanistic

Follistatin-344 (FS-344)

Activin-binding glycoprotein isoform

A myostatin-binding protein with dramatic animal results and essentially no human data for the administered protein. The gap between the two is the whole story.

1studies1Available to members
DSIP

DSIP

Nonapeptide, putative sleep modulator

Named for an effect that later work struggled to reproduce. A nine-amino-acid peptide with fifty years of inconsistent literature and no established receptor.

Mechanistic1studies1Available to members
Epitalon

Epitalon

Synthetic tetrapeptide

A four-amino-acid peptide carrying extraordinary longevity claims on an evidence base that is almost entirely one research group.

Mechanistic1studies1Available to members
KPV

KPV

Alpha-MSH C-terminal tripeptide

The three-residue anti-inflammatory tail of alpha-MSH, with consistent preclinical gut and skin data and no completed human trial.

Preclinical1studies1Available to members
Humanin

Humanin

Mitochondrial-derived peptide

A peptide encoded in mitochondrial DNA, of real scientific interest as a signalling molecule, with no interventional human trial of it as a therapy.

Preclinical2studies1Available to members

Vial imagery throughout this archive is illustration. Nothing here is a product, nothing is offered for sale, and nothing on this site is intended for human use. Guides describe what the published research reports; they do not describe what anyone should do. The community rules explain how that line is enforced.